|
| |
FDA
veröffentlicht Liste potenziell gefährlicher Medikamente, 8.
September 2008
|
| Schlüsselwörter:
FDA-Liste, gefährliche Medikamente, TNF-Blocker, Phenytoin,
Cymbalta, Arzneimittel, alter, Notfallbehandlung,
Medikamenten-Nebenwirkung, ältere Patienten, anaphylaktischer
Schock, unverträglichkeit, Ekzem, Juckreiz, Lyell-Syndrom, Insulin,
Digoxin, Marcumar, Krankheit, Studie, Therapie, Behandlung,
gefährlich, medikament, Krankheit, Studie, Therapie, Behandlung, Medikament und Studien. |
|
"Die
US-amerikanische Zulassungsbehörde FDA hat erstmals
eine Liste von 20 Medikamenten veröffentlicht,
deren Sicherheit derzeit untersucht wird...Die
Listung eines Medikaments bedeute keineswegs, dass
die Patienten das Medikament nicht mehr einnehmen
sollen...“ Mehr
im Ärzteblatt...
(Quelle: rme/aerzteblatt.de)
|
|
Potential
Signals of Serious Risks/New Safety
Information Identified by the Adverse
Event Reporting System (AERS) January
- March 2008
|
|
Product
Name: Active Ingredient (Trade)
or Product Class
|
Potential
Signal of Serious Risk/New Safety
Information
|
|
Arginine
Hydrochloride Injection (R-Gene 10)
|
Pediatric
overdose due to labeling / packaging
confusion
|
|
Desflurane
(Suprane)
|
Cardiac
arrest
|
|
Duloxetine
(Cymbalta)
|
Urinary
retention
|
|
Etravirine
(Intelence)
|
Hemarthrosis
|
|
Fluorouracil
Cream (Carac) and Ketoconazole Cream (Kuric)
|
Adverse
events due to name confusion
|
|
Heparin
|
Anaphylactic-type
reactions
|
|
Icodextrin
(Extraneal)
|
Hypoglycemia
|
|
Insulin
U-500 (Humulin R)
|
Dosing
confusion
|
|
Ivermectin
(Stromectol) and Warfarin
|
Drug
interaction
|
|
Lapatinib
(Tykerb)
|
Hepatotoxicity
|
|
Lenalidomide
(Revlimid)
|
Stevens
Johnson Syndrome
|
|
Natalizumab
(Tysabri)
|
Skin
melanomas
|
|
Nitroglycerin
(Nitrostat)
|
Overdose
due to labeling confusion
|
|
Octreotide
Acetate Depot (Sandostatin LAR)
|
Ileus
|
|
Oxycodone
Hydrochloride Controlled-Release (Oxycontin)
|
Drug
misuse, abuse and overdose
|
|
Perflutren
Lipid Microsphere (Definity)
|
Cardiopulmonary
reactions
|
|
Phenytoin
Injection (Dilantin)
|
Purple
Glove Syndrome
|
|
Quetiapine
(Seroquel)
|
Overdose
due to sample pack labeling confusion
|
|
Telbivudine
(Tyzeka)
|
Peripheral
neuropathy
|
|
Tumor
Necrosis Factor (TNF) Blockers
|
Cancers
in children and young adults
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|